Zobrazeno 1 - 10
of 63
pro vyhledávání: '"R. Deepashree"'
Publikováno v:
Journal of Pure and Applied Microbiology, Vol 18, Iss 3, Pp 1729-1740 (2024)
Multidrug-resistant (MDR) Gram-negative bacterial infections have emerged as a major public health concern. The aim of the present study was to detect the rate of infections due to MDR Gram-negative bacteria (GNB) in a tertiary care hospital, the rat
Externí odkaz:
https://doaj.org/article/119dfbbc0b704b4283d319c6880d08f4
Autor:
Mahadevaiah Neelambike Sumana, Yogeesh D. Maheshwarappa, Morubagal Raghavendra Rao, R. Deepashree, M. V. S. Krishna Karthik, Nikita K. Shah
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
Salmonella enterica serovar Newport is a human pathogen underreported in most developing countries. It is known for causing gastroenteritis and extraintestinal infections. In this case report, we report the case of ceftriaxone-resistant Salmonella en
Externí odkaz:
https://doaj.org/article/51df26cfda904c35a3cddb4001904626
Autor:
Neetha S. Murthy, M.N. Sumana, A. Tejashree, Vidyavathi B. Chitharagi, Rashmi P. Mahale, Murubagal Raghavendra Rao, G.S. Sowmya, Ranjitha Shankare Gowda, R. Deepashree, S.R. Sujatha
Publikováno v:
Journal of Pure and Applied Microbiology, Vol 17, Iss 3, Pp 1554-1559 (2023)
COVID-19 detection via lateral flow antigen assays (LFA) are rapid and economically acquiescent to infrastructure facile healthcare settings. Early, prompt identification of cases to facilitate patient isolation and supportive management is the essen
Externí odkaz:
https://doaj.org/article/b41726e144944d1b83544e4498cae90f
Publikováno v:
Journal of Pure and Applied Microbiology, Vol 16, Iss 2, Pp 885-890 (2022)
Enterobacterales particularly which are resistant to carbapenem group of antibiotics (CRE) are precariously being reported worldwide. Last option for treating the infections caused by CRE are polymyxin E (Colistin) and polymyxin B. Resistance to poly
Externí odkaz:
https://doaj.org/article/a050811d988e4cebb28ae9b27179f2d8
Publikováno v:
Journal of Laboratory Physicians, Vol 14, Iss 03, Pp 362-364 (2022)
Elizabethkingia is ubiquitary aerobic bacillus abundantly found in the community as well as hospital environments. Elizabethkingia meningoseptica is an emerging nosocomial pathogen with an elemental ability to acclimate and survive in diversified env
Externí odkaz:
https://doaj.org/article/bc91b16aee424e9eadff30ead55fee50
Autor:
Laskar, Abdul Mannan, R, Deepashree, Bhat, Prasanna, Pottakkat, Biju, Narayan, Sunil, Sastry, Apurba Sankar *, Sneha, R
Publikováno v:
In AJIC: American Journal of Infection Control July 2018 46(7):775-780
Autor:
Jyoti Nain, R Deepashree, Pratibha Tamang, Prasanna Bhat, Suman Prakash, R Sneha, T Kalpana, G Anitha, Apurba Sankar Sastry
Publikováno v:
Journal of Current Research in Scientific Medicine, Vol 4, Iss 2, Pp 98-103 (2018)
Introduction: Gram staining of smears prepared from positively flagged blood culture bottles plays a vital role because its accurate interpretation helps the clinicians to modify empirical therapy as well as to perform the direct susceptibility test,
Externí odkaz:
https://doaj.org/article/c330af974cfd439985f23cbd98d8f10d
Publikováno v:
In AJIC: American Journal of Infection Control 1 May 2017 45(5):498-501
Publikováno v:
International journal of health sciences. :3044-3053
Introduction: Hepatitis C virus still remains the major concern of post-transfusion viral infection causing chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide. Serological detection of anti-HCV IgG antibody is the mainstay for
Autor:
Tarun Bhatnagar, Sirshendu Chaudhuri, Manickam Ponnaiah, Pragya D Yadav, R Sabarinathan, Rima R Sahay, Faheem Ahmed, S Aswathy, Pankaj Bhardwaj, Anil Bilimale, M Santhosh Kumar, M. Logaraj, Uday Narlawar, C Palanivel, Prakash Patel, Sanjay K Rai, Vartika Saxena, Arvind Singh, Jeromie WV Thangaraj, Ashwini Agarwal, Yasir Alvi, null Amoghashree, P Ashok, Dinesh Babu, Yogesh Bahurupi, Sangita Bhalavi, Priyamadhaba Behera, Priyanka Pandit Biswas, Jaykaran Charan, Nishant Kumar Chauhan, KB Chetak, Lalit Dar, Ayan Das, R Deepashree, Minakshi Dhar, Rahul Dhodapkar, TS Dipu, Mridu Dudeja, Manisha Dudhmal, Ravisekhar Gadepalli, Mahendra Kumar Garg, AV Gayathri, Akhil Dhanesh Goel, H Basavana Gowdappa, Randeep Guleria, Manoj Kumar Gupta, Farzana Islam, Mannu Jain, Vineet Jain, M Lanord Stanley Jawahar, Rajendra Joshi, Shashi Kant, Sitanshu Sekhar Kar, Deepjyoti Kalita, Meenakshi Khapre, Satyendra Khichar, Sarika Prabhakar Kombade, Sunil Kohli, Abhinendra Kumar, Anil Kumar, Deepak Kumar, Kiran G Kulirankal, KV Leela, Triparna Majumdar, Baijayantimala Mishra, Puneet Misra, Sanjeev Misra, Prasanta Raghab Mohapatra, M Narayana Murthy, Dimpal A Nyayanit, Manish Patel, Monika Pathania, Savita Patil, Binod Kumar Patro, Ramniwas Jalandra, Pragati Rathod, Naimesh Shah, Anita Shete, Deepak Shukla, M Shwethashree, Smita Sinha, MN Sumana, Ashish Surana, Anjan Trikha, A Tejashree, Mahalingam Venkateshan, G Vijaykrishnan, Sarita Wadhava, Naveet Wig, Nivedita Gupta, Priya Abraham, Manoj V Murhekar
Publikováno v:
International Journal of Infectious Diseases. 122:693-702
India introduced BBV152/Covaxin and AZD1222/Covishield vaccines in January 2021. We estimated the effectiveness of these vaccines against severe COVID-19 among individuals aged ≥45 years.We did a multi-centric, hospital-based, case-control study be